Raras
Buscar doenças, sintomas, genes...
Meningite meningocócica
ORPHA:33475CID-10 · G01*CID-11 · 1C1C.0DOENÇA RARA

Uma doença bacteriana grave e de início rápido, causada pela bactéria *Neisseria meningitides*. Ela geralmente, mas nem sempre, se manifesta com manchas na pele (pontinhos vermelhos ou manchas roxas que não desaparecem quando você os aperta). Com o tempo, surgem sinais de meningite: febre, vômitos, dor de cabeça, sensibilidade à luz (fotofobia) e rigidez na nuca. Mais tarde, pode levar a confusão mental, delírio (estado de confusão e agitação) e sonolência excessiva. Em bebês e crianças pequenas, a rigidez na nuca e a sensibilidade à luz muitas vezes não aparecem. Nesses casos, os sinais podem ser menos específicos, como irritabilidade, choro inconsolável, dificuldade para mamar ou se alimentar e moleira estufada (abaulada). A meningite meningocócica também pode se apresentar como parte de uma infecção generalizada (sepse) em recém-nascidos, seja no início ou mais tarde após o nascimento. A doença é potencialmente fatal. Pacientes que sobrevivem podem desenvolver sequelas neurológicas, como perda auditiva (surdez), convulsões, espasticidade (rigidez e dificuldade de movimento), problemas de atenção e deficiência intelectual.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença bacteriana grave e de início rápido, causada pela bactéria *Neisseria meningitides*. Ela geralmente, mas nem sempre, se manifesta com manchas na pele (pontinhos vermelhos ou manchas roxas que não desaparecem quando você os aperta). Com o tempo, surgem sinais de meningite: febre, vômitos, dor de cabeça, sensibilidade à luz (fotofobia) e rigidez na nuca. Mais tarde, pode levar a confusão mental, delírio (estado de confusão e agitação) e sonolência excessiva. Em bebês e crianças pequenas, a rigidez na nuca e a sensibilidade à luz muitas vezes não aparecem. Nesses casos, os sinais podem ser menos específicos, como irritabilidade, choro inconsolável, dificuldade para mamar ou se alimentar e moleira estufada (abaulada). A meningite meningocócica também pode se apresentar como parte de uma infecção generalizada (sepse) em recém-nascidos, seja no início ou mais tarde após o nascimento. A doença é potencialmente fatal. Pacientes que sobrevivem podem desenvolver sequelas neurológicas, como perda auditiva (surdez), convulsões, espasticidade (rigidez e dificuldade de movimento), problemas de atenção e deficiência intelectual.

Pesquisas ativas
7 ensaios
130 total registrados no ClinicalTrials.gov
Publicações científicas
1.667 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
All ages
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G01*
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
2 sintomas
🩸
Sangue
2 sintomas
🧠
Neurológico
1 sintomas
👂
Ouvidos
1 sintomas
❤️
Coração
1 sintomas
🛡️
Imunológico
1 sintomas

+ 22 sintomas em outras categorias

Características mais comuns

90%prev.
Febre
Muito frequente (99-80%)
90%prev.
Rigidez de nuca
Muito frequente (99-80%)
90%prev.
Hipoglicorraquia
Muito frequente (99-80%)
90%prev.
Pescoço rígido
Muito frequente (99-80%)
90%prev.
Pleocitose do LCR
Muito frequente (99-80%)
90%prev.
Aumento da concentração de proteína no LCR
Muito frequente (99-80%)
35sintomas
Muito frequente (6)
Frequente (9)
Ocasional (13)
Muito raro (7)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 35 características clínicas mais associadas, ordenadas por frequência.

FebreFever
Muito frequente (99-80%)90%
Rigidez de nucaNuchal rigidity
Muito frequente (99-80%)90%
HipoglicorraquiaHypoglycorrhachia
Muito frequente (99-80%)90%
Pescoço rígidoStiff neck
Muito frequente (99-80%)90%
Pleocitose do LCRCSF pleocytosis
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.667PubMed
Últimos 10 anos200publicações
Pico201936 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado4
3Fase 37
2Fase 23
1Fase 11
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Meningite meningocócica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

130 ensaios clínicos encontrados, 7 ativos.

Distribuição por fase
NCT05087056 · Safety, Tolerability, and Immunogenicity of MenABCWY Adminis…Ativo
PHASE2
NCT06113198 · A Study on the Immune Response and Safety of a Vaccine Again…Ativo
PHASE4
NCT06226714 · A Clinical Trial of ACYW135 Group Meningococcal Polysacchari…Ativo
PHASE3
NCT06700148 · A Clinical Trial of ACYW135 Group Meningococcal Polysacchari…Ativo
PHASE3
NCT06131554 · A Clinical Trial to Evaluate the Immunogenicity and Safety o…Ativo
PHASE3
NCT07374510 · Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conj…Em breve
PHASE1
NCT03549325 · A Study Assessing Colonisation & Immunogenicity After Nasal …Encerrado
NA
NCT04685850 · Long-term Sequelae of Childhood Meningitis and Meningococcal…Encerrado
NCT03295318 · Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in …Concluído
PHASE2
NCT04665791 · A Human Controlled Infection Study with Neisseria Lactamica …Concluído
NA
NCT04061382 · Sero-epidemiological Survey of England in 2019/2020 - COVID-…Concluído
NCT04707391 · Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in…Concluído
PHASE3
NCT05252715 · Immunogenicity and Safety of Meningococcal ACYW135 Polysacch…UNKNOWN
PHASE3
NCT06337071 · A Study of the ACYW135 Meningococcal Polysaccharide Conjugat…UNKNOWN
PHASE2
NCT03493919 · A Sourcing Study to Collect Human Blood Samples From Healthy…Concluído
PHASE4
NCT02864927 · Postmarketing Surveillance Study for Use of Menactra® in the…Concluído
PHASE4
NCT02699840 · Observational Safety Study of Menactra® Administered Under S…Concluído
NCT02752906 · Immunogenicity and Safety of a Booster Dose of an Investigat…Concluído
PHASE3
NCT03205371 · Immunogenicity and Safety of a Meningococcal Conjugate Vacci…Concluído
PHASE3
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
351 papers (10 anos)
#1

Evaluation of Immune Risk Factors for Developing Complications After Bacterial Meningitis in Children.

Journal of child neurology2026 Apr

This study investigates selected components of the immune system and the prevalence of single-nucleotide polymorphisms in genes involved in the immune response in children following bacterial meningitis, with particular focus on their potential role in the development of postinfectious complications. The study included 47 children hospitalized with pneumococcal or meningococcal meningitis between 2010 and 2020. Analyses involved leukocyte profiles, immunoglobulin levels (IgA, IgM, IgG), complement activity (C3, C4, CH50), and 11 single-nucleotide polymorphisms across 7 genes. Data on complications were collected from medical records, follow-ups, and patient surveys. Complications occurred in 59.6% of cases, with cognitive impairment, focal neurologic deficits, subdural effusion, and hearing disorders being most common. CH50 defects showed a statistical trend toward an increased risk of neurologic complications (P = .064), and the TIRAP rs8177374 single-nucleotide polymorphism demonstrated a borderline trend toward significance (P = .054). Bacterial meningitis may lead to long-term complications. Complement system disturbances and genetic predispositions are important prognostic factors influencing outcomes.

#2

Nigeria's post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications.

Journal of public health in Africa2026

Global health emergencies consistently expose and exacerbate vaccine inequities, with high-income countries prioritising their populations and leaving low- and middle-income countries (LMICs) facing delays and shortages. Diseases primarily affecting LMICs receive limited attention from global vaccine developers because of perceived low market value and limited financial return, further entrenching these disparities. Africa's limited investment in vaccine manufacturing has heightened its vulnerability during outbreaks, including yellow fever, Ebola, meningococcal meningitis, mpox, and most recently, coronavirus disease 2019 (COVID-19). This study examines the barriers to vaccine equity in Africa and critically analyses Nigeria's post-COVID-19 efforts to establish a viable, local vaccine manufacturing ecosystem. The research focuses on Nigeria within the broader African vaccine manufacturing landscape, using it as a case study to explore both national and continental dynamics. The study draws on document analysis of strategic plans, regulatory reports, and partnership announcements, complemented by qualitative insights from key informant interviews with stakeholders involved in vaccine policy, regulation, and production in Nigeria and across West Africa. Post-pandemic momentum has catalysed significant shifts: Nigeria has developed a national vaccine manufacturing strategy and secured international partnerships and financing commitments. The regulatory authority, National Agency for Food and Drug Administration and Control (NAFDAC), achieved the World Health Organization (WHO) Maturity Level 3 status, marking critical progress. Nonetheless, persistent gaps remain in research and development capacity, workforce development, regulatory agility, and infrastructure readiness. While Nigeria has made notable progress since the COVID-19 pandemic, sustainable vaccine manufacturing requires long-term investment in research and development, policy reform, skills development, and regional cooperation. Failure to address these challenges systematically risks undermining current gains. This article provides insights to support ongoing and future investments in Nigeria's vaccine manufacturing sector, guiding government policy, international partnerships, and potential investors.

#3

Epidemiology and characteristics of bacterial meningitis of children with cerebrospinal fluid leakage or cochlear implant.

Journal of the Pediatric Infectious Diseases Society2026 Mar 09

Cerebrospinal (CSF) fluid leakage is a recognized risk factor for bacterial meningitis. Few data are published concerning bacterial meningitis in children with cerebrospinal fluid leakage, and the impact of 13 valent pneumococcal conjugate vaccination (PCV13) in this population is not well known. The aim of this study was to describe the epidemiology of bacterial meningitis in children with known CSF leakage.Methods: Among all bacterial meningitis in children > 3 months old, we analyzed those with known CSF leakage (meningeal breach and/or cochlear implant resulting in meningitis) in a nationwide prospective cohort between 2001 and 2024 in France, with 227 pediatric wards and 168 microbiology departments. Of 5,879 cases of bacterial meningitis in children over 3 months old, 251 (4.3%) were associated with known CSF leakage. In this population, Streptococcus pneumoniae (78.9%) was the most frequent bacteria involved, followed by Haemophilus influenzae (10%), mainly non typeable strains. Two cases of Neisseria meningitidis were recorded and only in children with cochlear implant. For children with known CSF leakage, in late PCV13 period, PCV13, PCV15, PCV20, PCV21 and PPSV23 serotypes accounted for 14%, 16.3%, 37.2%, 79.1% and 27.9%, respectively. In this population, serotype 23B was the most frequent (18.6%), followed by 11A (9.3%), 15A (9.3%), 19F (7%), 3 (4.7%) and 19A (2.3%). Bacterial meningitis in children with known CSF leakage is largely due to pneumococci and now mainly due to serotypes not included in PCV13. Only two cases of meningococcal meningitis were found and only for children with cochlear implant.

#4

Estimating the impact of decreasing vaccination response times for outbreaks of vaccine-preventable diseases in low- and middle-income countries.

BMC global and public health2026 Jan 21

The 7-1-7 targets are gaining traction as measurable targets for assessing a country's readiness to detect and respond to outbreaks of infectious diseases. The targets are outbreak detection within 7 days of emergence, notification to health authorities within 1 day, and key early response actions commenced within another 7 days. For outbreaks of measles, cholera, yellow fever, and meningococcal meningitis, we estimated the impact of initiating outbreak response immunisation (ORI) within 15 days of outbreak emergence, relative to the mean ORI response time for each disease in low- and middle-income countries (LMICs) since 2000. Initiating ORI within 15 days of outbreak emergence aligns with the 7-1-7 targets and supports outbreak containment. Using agent-based models for four diseases, a status quo and series of 'Faster response' scenarios were compared for simulated outbreaks of each disease, with a 15-day ORI response time as the minimum. The Starsim modelling framework was used to build the models to provide a single common software and analysis architecture for all models while having the flexibility to account for very different modes of transmission across the diseases being modelled. The models were calibrated to epidemiological and programmatic response data for 51 measles, 40 cholera, 24 meningococcal meningitis, and 88 yellow fever outbreaks in LMICs. In a synthetic model population, a 15-day ORI response could avert: 80% of cases from cholera outbreaks relative to a historical response time of 105 days, 35% of cases from meningococcal meningitis outbreaks relative to a historical response time of 75 days, 0-35% of cases from yellow fever outbreaks relative to a historical response time of 105 days (depending on routine vaccine coverage and environmental suitability), and 0-55% of cases from measles outbreaks relative to a historical response time of 120 days (depending on routine vaccine coverage). Improvements made to ORI response time could reduce disease burden and decrease the risk of large outbreaks of vaccine-preventable diseases in LMICs. Efforts to improve ORI timeliness should be prioritised to higher risk settings, and it was clear that even a slow vaccination response was beneficial relative to no response at all.

#5

High risk and low incidence diseases: Meningococcal disease.

The American journal of emergency medicine2026 Jan

Meningococcal disease is a serious condition that carries with it a high rate of morbidity and mortality. This review highlights the pearls and pitfalls of meningococcal disease, including presentation, diagnosis, and management in the emergency department (ED) based on current evidence. Invasive meningococcal disease is a severe, rapidly progressive infection caused by Neisseria meningitidis associated with high morbidity and mortality. Emergency physicians must maintain a high index of suspicion, as early symptoms may mimic a benign viral illness, potentially delaying treatment with serious consequences. This early phase is typically followed by the emergence of more specific features of meningococcal infection, such as meningococcal meningitis, meningococcemia, or a combination of both. Suspected cases warrant immediate implementation of droplet precautions and strict isolation to reduce the risk of healthcare worker exposure and secondary transmission. Prompt treatment, ideally within one hour of clinical suspicion, is essential. Management includes empiric parenteral antibiotics, and in cases of suspected meningitis, adjunctive corticosteroids should be administered prior to or concurrently with the first antibiotic dose. Patients with meningococcemia and shock require aggressive fluid resuscitation, vasopressor support as indicated, and prompt admission to a critical care setting. All close contacts of confirmed cases should receive chemoprophylaxis, regardless of their meningococcal immunization status. An understanding of meningococcal disease can assist emergency clinicians in diagnosing and managing this potentially deadly disease.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC825 artigos no totalmostrando 198

2025

New title: Re-evaluating environmental associations with meningitis risk across Africa.

Wellcome open research
2026

Nigeria's post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications.

Journal of public health in Africa
2026

Epidemiology and characteristics of bacterial meningitis of children with cerebrospinal fluid leakage or cochlear implant.

Journal of the Pediatric Infectious Diseases Society
2025

Disseminated gonococcal infection secondary to a rare homozygous mutation resulting in complement factor I deficiency.

Journal of human immunity
2026

Estimating the impact of decreasing vaccination response times for outbreaks of vaccine-preventable diseases in low- and middle-income countries.

BMC global and public health
2025

[Epidemiological characteristics and analysis of onset-to-diagnosis and diagnosis-to-report time intervals for meningococcal meningitis in Zhejiang Province from 2014 to 2024].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2025

A Pediatric Case of Serogroup Y Meningococcal Meningitis in a 12-Year-Old Boy Combined with Respiratory Infection of Three Species of Viruses in China.

Infection and drug resistance
2025

Parents Who Accepted the Meningococcal Conjugate Vaccine Were More Aware of the Severity of the Disease and Risks.

Acta paediatrica (Oslo, Norway : 1992)
2025

Investigating health professionals' understanding and risk perception of the effect of climate change on health. A cross-sectional study at three hospitals in Sunyani, Ghana.

Journal of public health research
2025

Anti-cytokine autoantibodies linked to susceptibility, bacterial load, and outcome in pneumococcal meningitis: prospective cohort studies in CNS infections, Alzheimer's disease, and Parkinson's disease.

EBioMedicine
2026

High risk and low incidence diseases: Meningococcal disease.

The American journal of emergency medicine
2025

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond.

Human vaccines &amp; immunotherapeutics
2026

Evaluation of Immune Risk Factors for Developing Complications After Bacterial Meningitis in Children.

Journal of child neurology
2025

Modelling of strategies for the introduction and routine use of multivalent meningococcal conjugate vaccines (MMCVs) in the African meningitis belt.

PloS one
2025

Neisseria Meningitidis Carriage Among Hajj and Umrah Pilgrims: A Systematic Review and Meta-Analysis.

European journal of medical research
2025

Modeling Neisseria meningitidis transmission dynamics and the impact of pentavalent vaccination targeting serogroups A, C, W-135, Y, and X in the African meningitis belt.

Infectious Disease Modelling
2025

Design of New Primer Sets for the Development of a Loop-Mediated Isothermal Amplification for Rapid Detection of Neisseria meningitidis.

Current issues in molecular biology
2025

Application of a novel virus-like particle platform to the development of Neisseria vaccines.

Journal of biotechnology
2025

Bibliometric visualization of global research trends in meningococcal meningitis.

International journal of surgery (London, England)
2025

Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries.

BMJ global health
2025

Meningococcal B vaccine co-administration in older adolescents and young adults and potential missed opportunities for vaccination in the United States: a retrospective claims database analysis.

Current medical research and opinion
2025

Sequelae following an epidemic of meningococcal meningitis in Niger in 2022.

PloS one
2025

Epidemiological and Clinical Features of Meningococcal Meningitis in Infants - China, 2006-2023.

China CDC weekly
2025

Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learning.

PloS one
2025

A Case Cluster of Aseptic Meningitis Associated With a Newly Identified Recombinant Echovirus 6/Coxsackievirus B1 Enterovirus.

The Journal of infectious diseases
2025

Modelling human response to information in voluntary vaccination behaviour using epidemic data.

Mathematical biosciences and engineering : MBE
2025

A Cluster of Meningococcal Serogroup W135 Infections: A Case Series.

Cureus
2025

Successfully treated myopericarditis and acute heart failure due to severe Neisseria meningitidis infection: a case report.

Diagnostic microbiology and infectious disease
2025

Spinal Phlegmon Secondary to Neisseria meningitidis Meningitis With Possible Herpes Simplex Virus 1 Co-infection in an Immunocompetent Pediatric Patient.

Cureus
2025

Outbreak of Neisseria meningitidis serogroup B in Aragón, Spain, January to February 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Hydrocephalus and Cerebral Small Vessel Disease in an Adult With Meningococcal Meningitis and Dilated Cardiomyopathy: A Fatal Outcome.

Clinical case reports
2025

[Clinical characteristics and serogroup analysis of 16 pediatric cases of meningococcal meningitis].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Addressing challenges in meningococcal meningitis prevention: Key highlights from recent cases in Xining, China.

Journal of infection and public health
2025

Vaccinations for Hajj: Enhancing health and global health security.

Travel medicine and infectious disease
2024

Assessing the Impact of TLR4 rs4986790 Polymorphism on Bacterial Meningitis Risk: A Systematic Review and Meta-Analysis.

Annals of Indian Academy of Neurology
2024

Characterisation and Immunogenicity of Neisseria cinerea outer membrane vesicles displaying NadA, NHBA and fHbp from Neisseria meningitidis serogroup B.

Frontiers in immunology
2024

Hajj vaccination strategies: Preparedness for risk mitigation.

Journal of infection and public health
2024

[Analysis on incidence trend of meningococcal meningitis and major pathogenic serogroups of Neisseria meningitidis in China, 1990-2023].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
2024

Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.

PloS one
2024

Fatal case of meningococcal meningitis in a child from rural Bhutan: A case report.

Clinical case reports
2024

[Community-Acquired Bacterial Meningoencephalitis: The New Guideline].

Deutsche medizinische Wochenschrift (1946)
2024

[Meningococcal meningitis in Chile between 1990 and 2019].

Andes pediatrica : revista Chilena de pediatria
2024

Emerging Meningococcal B Meningitis in Japan: A Case Report of a 50-Year-Old Japanese Man with Diabetes.

The American journal of case reports
2024

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Initially Presenting as Septic Meningoencephalitis in a 16-Year-Old Male.

European journal of case reports in internal medicine
2024

Developing a Novel Murine Meningococcal Meningitis Model Using a Capsule-Null Bacterial Strain.

Diagnostics (Basel, Switzerland)
2023

Positive effects of health behaviors acquired during the COVID-19 pandemic process on the prevention of other infectious diseases.

Turkish journal of medical sciences
2024

Severe Meningococcal Meningitis Revealing a Novel Form of Properdin Deficiency in a Previously Healthy 13-Year-old Child.

The Pediatric infectious disease journal
2024

Management of a Neisseria meningitidis case: factors that guarantee the effectiveness of supporting Public Health actions.

Annali di igiene : medicina preventiva e di comunita
2024

Determining the bacterial and viral meningitis trend in Iraq from 2007 till 2023 using joinpoint regression.

Heliyon
2024

PCR-positive meningococcal CSF infection without pleocytosis but high IL-6 and IL-8.

Infection
2024

Pictures in Medicina Intensiva. Endogenous endophthalmitis in a meningococcal meningitis case.

Medicina intensiva
2024

Neisseria meningitidis with decreased susceptibility to penicillin G and molecular characterization of the penA gene in strains isolated at University Hospital Centers of Casablanca and Marrakech (Morocco).

The Pan African medical journal
2024

An Outbreak of Serogroup Y Meningococcal Meningitis in a Private Secondary Vocational School - Guangzhou City, Guangdong Province, China, 2023.

China CDC weekly
2024

An isothermal CRISPR- based lateral flow assay for detection of Neisseria meningitidis.

Annals of clinical microbiology and antimicrobials
2024

Investigation of a bacterial meningitis cluster in a refugee settlement, Obongi District, Uganda, March 2023.

The Pan African medical journal
2024

Etiology, Clinical Presentation, and Outcomes of Bacterial Meningitis in Adult Patients: A Retrospective Study in Lithuania (2018-2021).

Medical science monitor : international medical journal of experimental and clinical research
2024

Meningococcal meningitis in Spain in the Horizon 2030: A position paper.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
2024

Determine the factors affecting the time to recovery of children with bacterial meningitis at Jigjiga university referral hospital in the Somali Regional State of Ethiopia: using the parametric shared frailty and AFT models.

BMC research notes
2024

The epidemiological profile of incidence and mortality from epidemics in complex humanitarian emergencies from 1990 to 2022 - A scoping review.

Tropical medicine &amp; international health : TM &amp; IH
2023

Twins with meningitis due to Neisseria meningitidis.

Germs
2024

Pneumonia in childhood bacterial meningitis-Experience from three continents.

Tropical medicine &amp; international health : TM &amp; IH
2024

Novel Pathogenic C5 Gene Variants in a Patient with Neisseria Meningitis and Diffuse Cutaneous HSV-1 Infection.

Journal of clinical immunology
2023

What Works for Controlling Meningitis Outbreaks: A Case Study from China.

Vaccines
2023

Impact of the COVID-19 pandemic on the infectious disease epidemiology.

Journal of preventive medicine and hygiene
2024

Vaccine-preventable Pediatric Acute Bacterial Meningitis in France: A Time Series Analysis of a 19-Year Prospective National Surveillance Network.

The Pediatric infectious disease journal
2023

Neisseria meningitidis accumulate in large organs during meningococcal sepsis.

Frontiers in cellular and infection microbiology
2023

Genetic variants linked to the phenotypic outcome of invasive disease and carriage of Neisseria meningitidis.

Microbial genomics
2023

Community pharmacists' knowledge, prospective and practice towards health related illness at Hajj and Umrah: A cross sectional study.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
2023

Association between contextual factors and coverage of the Acwy meningococcal vaccine, after three years of its overdue, in the vaccination calendar of adolescents in the state of Minas Gerais, Brazil: global space regressions.

BMC infectious diseases
2024

Serious Bacterial Infections Associated with Eculizumab: A Pharmacovigilance Study.

Internal medicine (Tokyo, Japan)
2023

Accuracy of antigen tests for meningococcal meningitis in cerebrospinal fluid: A diagnostic meta-analysis.

Tropical medicine &amp; international health : TM &amp; IH
2023

Trends in laboratory-confirmed bacterial meningitis (2012-2019): national observational study, England.

The Lancet regional health. Europe
2023

Meningococcal B septic shock, reactive pericarditis and public health.

The Medical journal of Australia
2023

[Invasive meningococcal disease: increased risk and vaccination prevention for immunocompromised patients].

MMW Fortschritte der Medizin
2023

Acute Bacterial Meningitis in Healthy Adult Patients: A Prospective Cohort Study.

Journal of clinical medicine
2023

Cerebrovascular complications in patients with community-acquired bacterial meningitis: occurrence and associated factors in the COMBAT multicenter prospective cohort.

BMC infectious diseases
2023

Serogroup B Meningococcal Sepsis and Meningitis Associated With Meningococcal Acute Otitis Media, and Paranasal Sinusitis in an Infant: A Case Report.

Cureus
2023

Epidemiology, clinical features and outcome of adults with meningococcal meningitis: a 15-year prospective nationwide cohort study.

The Lancet regional health. Europe
2023

Incidence and trends of 17 notifiable bacterial infectious diseases in China, 2004-2019.

BMC infectious diseases
2022

Guillain-Barre syndrome complicating Neisseria meningitidis infection.

Oxford medical case reports
2023

Trends in Neisseria meningitidis serogroups amongst patients with suspected cerebrospinal meningitis in the meningitis belt of Ghana: a 5-year retrospective study.

BMC infectious diseases
2023

Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico: A Need for Vaccination.

Tropical medicine and infectious disease
2022

[Immunogenicity of group A+C meningococcal polysaccharide conjugate vaccine in infants: A phase Ⅲ clinical trial study].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2022

Transtentorial herniation syndrome from meningococcal meningitis in a young woman: the case for neurocritical care.

BMJ case reports
2023

[Neisseria meningitidis and the increase of oral sex. A case report].

Revista internacional de andrologia
2022

Highly Similar Sequences of Mature IgA1 Proteases from Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenzae.

Pathogens (Basel, Switzerland)
2021

Vaccines and Senior Travellers.

Frontiers in aging
2021

The epidemiology of meningococcal meningitis: multicenter, hospital-based surveillance of meningococcal meningitis in Iraq.

IJID regions
2022

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis.

Human vaccines &amp; immunotherapeutics
2022

A systematic review and meta-analysis on the antibiotic resistance of Neisseria meningitidis in the last 20 years in the world.

Indian journal of medical microbiology
2022

[Research progress on immunogenicity evaluation of serogroup B meningococcal vaccine].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2022

Long-term impact of invasive meningococcal disease in children: SEINE study protocol.

PloS one
2022

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.

Vaccine
2022

A database study of clinical and economic burden of invasive meningococcal disease in France.

PloS one
2022

One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study.

Advances in therapy
2022

The Collateral Effect of COVID-19 on the Epidemiology of Airborne/Droplet-Transmitted Notifiable Infectious Diseases in Taiwan.

Antibiotics (Basel, Switzerland)
2022

Availability of polyamines affects virulence and survival of Neisseria meningitidis.

Journal of microbiology (Seoul, Korea)
2022

Impact of COVID-19 pandemic on vaccination against meningococcal C infection in Brazil.

Vaccine: X
2022

Enhancing Meningococcal Genomic Surveillance in the Meningitis Belt Using High-Resolution Culture-Free Whole-Genome Sequencing.

The Journal of infectious diseases
2022

Epidemiology and treatment of sepsis at a public pediatric emergency department.

Einstein (Sao Paulo, Brazil)
2022

Low Adherence to Pneumococcal Vaccination in Lung Cancer Patients in a Tertiary Care University Hospital in Southern Germany.

Vaccines
2022

Does social deprivation correlate with meningococcal MenACWY, Hib/MenC and 4CMenB/Meningococcal Group B vaccine uptake in Northern Ireland?

The Ulster medical journal
2022

Genetic workup as a complementary tool for the diagnosis of primary complement component deficiencies: a multicenter experience.

European journal of pediatrics
2022

Impact of meningococcal C conjugate vaccine on incidence of invasive meningococcal disease in an 18-year time series in Brazil and in distinct Brazilian regions.

Tropical medicine &amp; international health : TM &amp; IH
2021

Meningococcal Disease Burden in India: A Systematic Review and Meta-Analysis.

Microbiology insights
2021

[Epidemiological and Etiologic characteristics of Meningococcal meningitis in Xinjiang Uygur Autonomous Region,1960-2019].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
2022

Invasive meningococcal disease: Should the first episode prompt further investigation?

Journal of paediatrics and child health
2021

Impact of MenAfriVac on Meningococcal A Meningitis in Cameroon: A Retrospective Study Using Case-by-Case-Based Surveillance Data from 2009 to 2015.

Journal of tropical medicine
2021

An overview of bacterial meningitis epidemics in Africa from 1928 to 2018 with a focus on epidemics "outside-the-belt".

BMC infectious diseases
2021

Assessment of a Multiplex LAMP Assay (Eazyplex® CSF Direct M) for Rapid Molecular Diagnosis of Bacterial Meningitis: Accuracy and Pitfalls.

Microorganisms
2021

Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950-2018.

Innovation (Cambridge (Mass.))
2021

Pneumococcal Meningitis Outbreaks in Africa, 2000-2018: Systematic Literature Review and Meningitis Surveillance Database Analyses.

The Journal of infectious diseases
2021

Analysis of spatial-temporal distribution of notifiable respiratory infectious diseases in Shandong Province, China during 2005-2014.

BMC public health
2021

The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.

The Pan African medical journal
2021

[Primary meningococcal arthritis].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
2021

Meningococcal Meningitis with Waterhouse-Friderichsen Syndrome.

Journal of education &amp; teaching in emergency medicine
2021

Identification and structural investigation of potential novel drug candidates against lethal human pathogen.

Pakistan journal of pharmaceutical sciences
2021

Genetic variations of toll-like receptors: Impact on susceptibility, severity and prognosis of bacterial meningitis.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
2021

Meningococcal Carriage among Household Contacts of Patients with Invasive Meningococcal Disease in Kathmandu, Nepal: A Longitudinal Study.

Pathogens (Basel, Switzerland)
2021

Lactate-Induced Dispersal of Neisseria meningitidis Microcolonies Is Mediated by Changes in Cell Density and Pilus Retraction and Is Influenced by Temperature Change.

Infection and immunity
2021

Assessing vaccine introduction and uptake timelines in Gavi-supported countries: are introduction timelines accelerating across vaccine delivery platforms?

BMJ global health
2021

Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.

PloS one
2021

Antimeningococcal Vaccination Coverage Among Healthcare Workers in an Italian University Hospital.

Frontiers in public health
2021

Serogroup B invasive meningococcal disease (IMD) outbreak at a Japanese high school dormitory: An outbreak investigation report from the first IMD outbreak in decades.

Vaccine
2021

Meningococcal serotype W septic arthritis: Case series in children.

Journal of paediatrics and child health
2021

Meningococcal vaccines in China.

Human vaccines &amp; immunotherapeutics
2020

Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis.

Frontiers in medicine
2020

Interactions and Signal Transduction Pathways Involved during Central Nervous System Entry by Neisseria meningitidis across the Blood-Brain Barriers.

International journal of molecular sciences
2020

Meningococcal vaccines and protein-energy undernutrition in children in the African meningitis belt.

Vaccine
2021

Herpes simplex virus type 2 myelitis mimicking ICU-acquired weakness as a complication of meningococcal meningitis: A case report.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2020

Unusual presentation of meningococcal meningitis in the elderly and utility of CSF PCR testing.

Access microbiology
2020

Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.

Proceedings of the National Academy of Sciences of the United States of America
2020

4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.

PLoS pathogens
2020

Rapid Diagnosis of Meningococcal Meningitis in a Patient With Familial Mediterranean Fever by the FilmArray Meningitis/Encephalitis Panel: A Case Report.

The Neurohospitalist
2021

Primary immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2008-2017.

Human vaccines &amp; immunotherapeutics
2020

Profile and complexity of travel medicine consultations in Chile: unicentric cross-sectional study.

BMJ open
2020

Meningococcal meningitis and COVID-19 co-infection.

BMJ case reports
2020

A Case of Meningococcal and HSV-2 Meningitis in a Patient Being Treated with Ustekinumab for Pityriasis Rubra Pilaris.

European journal of case reports in internal medicine
2020

Diversification in immunogenicity genes caused by selective pressures in invasive meningococci.

Microbial genomics
2020

An Update on Meningococcal Vaccination.

Rhode Island medical journal (2013)
2020

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells.

Journal of visualized experiments : JoVE
2020

Long-term impacts of MenC vaccination campaign in the Salvador, Brazil metropolitan region: A comparison of pre- and post-vaccine periods.

Vaccine
2020

The important role of immunization in alcoholic and non-alcoholic chronic liver disease: A population-based study.

Journal of digestive diseases
2020

Miller Fisher syndrome following meningococcal meningitis.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.

BMC infectious diseases
2020

[Paroxysmal nocturnal hemoglobinuria treated with eculizumab in Wakayama, Japan: a retrospective analysis].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2020

Pediatric bacterial meningitis and meningococcal disease profile in a Brazilian General Hospital.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
2020

Surveillance system assessment in Guinea: Training needed to strengthen data quality and analysis, 2016.

PloS one
2020

COVID-19 and lessons learned from the pandemic wave of meningococcal meningitis (1985-1990).

Sudanese journal of paediatrics
2020

Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report.

Medicine
2020

Meningococcal infections among refugees and immigrants: silent threats of past, present and future.

Human vaccines &amp; immunotherapeutics
2019

Cuban Meningococcal Vaccine VA-MENGOC-BC:30 Years of Use and Future Potential.

MEDICC review
2020

Characteristics and outcome of spontaneous bacterial meningitis in patients with diabetes mellitus.

BMC infectious diseases
2020

The Origin of the Idea That Herpes Labialis Is of Prognostic Importance in Bacterial Meningitis.

European neurology
2020

An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.

Vaccine
2020

Cerebrospinal meningitis: a global disease with regional variability?

Neurologia i neurochirurgia polska
2020

Health workers' perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso.

BMC public health
2020

Differences in the courses of meningococcal and pneumococcal cerebrospinal meningitis.

Neurologia i neurochirurgia polska
2020

Validation of a New Rapid Detection Test for Detection of Neisseria meningitidis A/C/W/X/Y Antigens in Cerebrospinal Fluid.

Journal of clinical microbiology
2019

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery.

Journal of visualized experiments : JoVE
2019

MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa.

The Journal of infectious diseases
2019

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.

The Journal of infectious diseases
2019

Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.

The Journal of infectious diseases
2019

Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso.

The Journal of infectious diseases
2019

Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.

The Journal of infectious diseases
2019

Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.

The Journal of infectious diseases
2019

Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.

The Journal of infectious diseases
2019

A case report of multiple cerebral abscess formation complicating serogroup B Neisseria meningitidis meningitis.

BMC infectious diseases
2021

Subdural and subarachnoid empyema as a complication of an acute meningococcal meningitis.

Archives of disease in childhood
2019

Cerebrospinal meningitis: lessons learnt from Africa.

The Lancet. Infectious diseases
2019

Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2019

Meningococcal pneumonia: a review.

Pneumonia (Nathan Qld.)
2019

Gauging the epidemic potential of a widely circulating non-invasive meningococcal strain in Africa.

Microbial genomics
2019

Aseptic meningitis associated with routine infant immunisation visits that include the group B meningococcal vaccine, 4CMenB.

Archives of disease in childhood
2019

Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
2019

A Systematic Review for Vaccine-Preventable Diseases on Ships: Evidence for Cross-Border Transmission and for Pre-Employment Immunization Need.

International journal of environmental research and public health
2019

Meningitis vaccines in children: what have we achieved and where next?

Current opinion in infectious diseases
2019

Carbohydrates in Vaccine Development.

Current drug delivery
2019

Neisseria meningitidis and cytomegalovirus simultaneous detection in the filmarray meningitis/encephalitis panel and its clinical relevance.

IDCases
2019

Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells as a Cellular Model to Study Neisseria meningitidis Infection.

Frontiers in microbiology
2019

A case of a FilmArray® ME false negative in meningococcal meningitis.

The Journal of infection
2019

[Genotypes of Neisseria meningitidis isolates in patients with meningococcal meningitis in Paraguay, 1996-2015Genótipos de Neisseria meningitidis isolados de pacientes com doença meningocócica no Paraguai, 1996-2015].

Revista panamericana de salud publica = Pan American journal of public health
2019

Epidemiological burden of meningococcal disease in Latin America: A systematic literature review.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2018

Seasonal upsurge of pneumococcal meningitis in the Central African Republic.

Wellcome open research
2019

Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis.

Vaccine
2019

Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

Journal of global health
2019

Meningococcal strain evolution, dusty dry air and respiratory tract infections: An explosive relationship.

EBioMedicine
2019

Meningococcal purpura fulminans and severe myocarditis with clinical meningitis but no meningeal inflammation: a case report.

BMC infectious diseases
2019

Fatal meningococcal meningitis in a 2-year-old child: A case report.

World journal of clinical cases
2019

Meningococcal Meningitis.

JAMA
2019

Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.

PLoS neglected tropical diseases
2018

Analysis of Death and Survival Factors Associated with Childhood Bacterial Meningitis at a Reference Pediatric Hospital in Antananarivo, Madagascar.

Journal of immunological sciences
2019

University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.

Emerging infectious diseases
2019

Intraventricular empyema caused by Neisseria meningitidis.

IDCases
2018

Elimination of Epidemic Meningitis in the African Region: Progress and Challenges: 2010-2016.

Journal of immunological sciences
2019

Pediatric meningococcocal meningitis in the acute phase: how much does it cost?

Italian journal of pediatrics
2019

[Analysis of epidemic characteristics for meningococcal meningitis in China during 2015-2017].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2019

[Efficacy, safety, and cost-effectiveness of meningococcal vaccines].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Ver todos os 825 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Meningite meningocócica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Meningite meningocócica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Evaluation of Immune Risk Factors for Developing Complications After Bacterial Meningitis in Children.
    Journal of child neurology· 2026· PMID 40956914mais citado
  2. Nigeria's post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications.
    Journal of public health in Africa· 2026· PMID 41810010mais citado
  3. Epidemiology and characteristics of bacterial meningitis of children with cerebrospinal fluid leakage or cochlear implant.
    Journal of the Pediatric Infectious Diseases Society· 2026· PMID 41800559mais citado
  4. Estimating the impact of decreasing vaccination response times for outbreaks of vaccine-preventable diseases in low- and middle-income countries.
    BMC global and public health· 2026· PMID 41559840mais citado
  5. High risk and low incidence diseases: Meningococcal disease.
    The American journal of emergency medicine· 2026· PMID 41016083mais citado
  6. Meningococcal Meningitis Complicated by Cerebral Venous Sinus Thrombosis Presenting as Pseudo-Subarachnoid Hemorrhage in a Toddler: A Case Report.
    Cureus· 2026· PMID 41939548recente
  7. Neonatal invasive meningococcal disease: Clinical case from Saudi Arabia and updated review of reported cases.
    J Infect Public Health· 2026· PMID 41894900recente
  8. First serogroup Y meningitis outbreak in Hubei Province Central China linked to adolescent immunization gaps.
    Sci Rep· 2026· PMID 41888240recente
  9. New title: Re-evaluating environmental associations with meningitis risk across Africa.
    Wellcome Open Res· 2025· PMID 41836644recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:33475(Orphanet)
  2. MONDO:0018059(MONDO)
  3. GARD:18809(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q7386479(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Meningite meningocócica
Compêndio · Raras BR

Meningite meningocócica

ORPHA:33475 · MONDO:0018059
Prevalência
1-9 / 100 000
Herança
Not applicable
CID-10
G01* · Meningite em doenças bacterianas classificadas em outra parte
CID-11
Ensaios
7 ativos
Início
All ages
Prevalência
0.0 (Europe)
MedGen
UMLS
C0025294
Repurposing
22 candidatos
ampicillinbacterial cell wall synthesis inhibitor
benzylpenicillinpenicillin binding protein inhibitor
cefotaximebacterial 50S ribosomal subunit inhibitor
+17 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades